HCA Healthcare Inc (NYSE: HCA) on Tuesday, soared 4.22% from the previous trading day, before settling in for the closing price of $319.57. Within the past 52 weeks, HCA’s price has moved between $289.98 and $417.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.69% annually for the last half of the decade. The company achieved an average annual earnings per share of 13.22%. With a float of $177.44 million, this company’s outstanding shares have now reached $249.98 million.
In an organization with 316000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 50.44%, operating margin of 21.64%, and the pretax margin is 12.07%.
HCA Healthcare Inc (HCA) Insider Updates
Observing investor behavior towards Medical Care Facilities industry stocks is more important than anything else. The insider ownership of HCA Healthcare Inc is 28.55%, while institutional ownership is 65.21%. The most recent insider transaction that took place on Feb 14 ’25, was worth 3,075,240. In this transaction SVP & Chief Human Res. Officer of this company sold 9,533 shares at a rate of $322.59, taking the stock ownership to the 15,412 shares. Before that another transaction happened on Feb 14 ’25, when Company’s Officer proposed sale 9,533 for $322.59, making the entire transaction worth $3,075,238.
HCA Healthcare Inc (HCA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 13.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.16% during the next five years compared to 16.93% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
HCA Healthcare Inc (HCA) is currently performing well based on its current performance indicators. A quick ratio of 0.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.17. Likewise, its price to free cash flow for the trailing twelve months is 14.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 21.99, a number that is poised to hit 5.78 in the next quarter and is forecasted to reach 27.96 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.86 million. That was better than the volume of 1.68 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.05%. Additionally, its Average True Range was 9.09.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 33.89%, which indicates a significant decrease from 79.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.54% in the past 14 days, which was higher than the 30.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $314.53, while its 200-day Moving Average is $345.76. However, in the short run, HCA Healthcare Inc’s stock first resistance to watch stands at $337.55. Second resistance stands at $342.03. The third major resistance level sits at $350.72. If the price goes on to break the first support level at $324.38, it is likely to go to the next support level at $315.69. Assuming the price breaks the second support level, the third support level stands at $311.21.
HCA Healthcare Inc (NYSE: HCA) Key Stats
Market capitalization of the company is 82.72 billion based on 248,342K outstanding shares. Right now, sales total 70,603 M and income totals 5,760 M. The company made 18,285 M in profit during its latest quarter, and 1,438 M in sales during its previous quarter.
